U:  P:        Forgot Password? Username?

Physician Registration


medical_05


Current Trials

Gastrointestinal GERD Rabeprazole 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Erosive GERD
Rabeprazole 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Erosive GERD PDF Print E-mail
  • The purpose of this study is to determine the safety and efficacy of Rabeprazole extended release (ER) 50 mg versus Esomeprazole 40 mg for healing and symptomatic relief among subjects with erosive gastroesophageal reflux disease (GERD).
< Prev   Next >
 
Privacy PolicyTerms of ServiceLogin